NYSE$ZTS
Zoetis · Q3 2025 earnings
Q3 2025 earnings · · Before market open · Investor relations
Briefing
Zoetis reported Q3 2025 revenue of $2.4B with net income attributable to Zoetis of $721M and diluted EPS of $1.63.
Revenue was $2.4 billion with net income attributable to Zoetis of $721 million and diluted EPS of $1.63. Companion animal and livestock franchises continued to drive organic growth.
- Q3 revenue $2.4B.
- Net income attributable to Zoetis $721M; diluted EPS $1.63.
- Companion animal portfolio remained the growth engine.
- Innovation pipeline and international expansion in focus.
Headline financials
Revenue & EPS history
Zoetis · Revenue · Quarterly
$2.4B
Revenue by segment
Zoetis · $2.15B total across 3 segments · Q3 2023
- Companion Animal$1.41B+11.3%65.7%
- Livestock$716M+1.1%33.3%
- Contract Mfg & Human Health$21M-8.7%1.0%
Forward guidance
The filing discusses Zoetis's outlook, capital deployment, and key risks without relying solely on numeric EPS guidance.
Tailwinds
- Zoetis cited execution on strategic priorities in the filing.
- Balance sheet and liquidity support continued operations.
Headwinds
- Macro, competitive, and cost pressures may affect margins.
- Segment mix and one-time items can affect comparability.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q3 2025
+0.4%
Avg return
Earnings day
-0.6%
Avg return
5 days after
+0.5%
Avg return
30 days after
55%
32 / 58 earnings
Positive
+8.1%
Q4 2018
Best reaction
-13.7%
Q3 2025
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +0.2% | -30.9% | -28.5% | |
| Q4 2025 | -2.4% | -2.4% | -10.1% | |
| Q3 2025 | -13.7% | -16.7% | -16.6% | |
| Q2 2025 | -3.7% | -2.9% | +0.9% | |
| Q1 2025 | -5.3% | +0.8% | +6.7% | |
| Q4 2024 | -5.1% | -10.0% | -7.3% | |
| Q3 2024 | -3.7% | -2.8% | -3.6% | |
| Q2 2024 | +5.7% | +6.0% | +6.7% | |
| Q1 2024 | +5.4% | +6.3% | +7.0% | |
| Q4 2023 | -6.4% | -4.2% | -11.6% | |
| Q3 2023 | +7.1% | +10.4% | +18.3% | |
| Q2 2023 | +4.8% | +5.6% | +3.9% | |
| Q1 2023 | +4.8% | +3.7% | -3.3% | |
| Q4 2022 | +7.3% | +5.4% | +1.9% | |
| Q3 2022 | -9.3% | -7.6% | +6.8% | |
| Q2 2022 | -3.1% | -5.9% | -12.9% | |
| Q1 2022 | -4.3% | -8.0% | -4.4% | |
| Q4 2021 | -0.7% | -2.6% | -1.4% | |
| Q3 2021 | +2.7% | +4.3% | +5.8% | |
| Q2 2021 | -1.4% | -2.9% | +2.4% | |
| Q1 2021 | -1.3% | -2.1% | +0.8% | |
| Q4 2020 | +1.3% | -4.0% | -8.6% | |
| Q3 2020 | -2.9% | -6.8% | -9.4% | |
| Q2 2020 | +0.7% | -0.5% | -0.3% | |
| Q1 2020 | -5.4% | -3.7% | +7.4% | |
| Q4 2019 | +0.8% | +0.5% | -12.2% | |
| Q3 2019 | -3.0% | -3.5% | +0.2% | |
| Q2 2019 | +7.4% | +11.1% | +13.8% | |
| Q1 2019 | +1.9% | -0.4% | -0.7% | |
| Q4 2018 | +8.1% | +7.5% | +9.8% | |
| Q3 2018 | +2.9% | +2.9% | +4.1% | |
| Q2 2018 | +6.5% | +7.5% | +5.3% | |
| Q1 2018 | -3.6% | -1.5% | +2.4% | |
| Q4 2017 | +7.1% | +7.9% | +13.6% | |
| Q3 2017 | +6.5% | +6.1% | +12.1% | |
| Q2 2017 | -1.6% | -3.4% | +4.9% | |
| Q1 2017 | +7.0% | +6.9% | +12.4% | |
| Q4 2016 | -4.8% | -3.0% | -2.1% | |
| Q3 2016 | +3.6% | +5.8% | +3.9% | |
| Q2 2016 | +3.4% | +2.2% | +3.1% | |
| Q1 2016 | +0.2% | — | — | |
| Q4 2015 | +3.4% | — | — | |
| Q3 2015 | +5.2% | — | — | |
| Q2 2015 | +0.3% | — | — | |
| Q1 2015 | -0.2% | — | — | |
| Q4 2014 | +4.3% | — | — | |
| Q3 2014 | +4.1% | — | — | |
| Q2 2014 | -2.8% | — | — | |
| Q1 2014 | +0.4% | — | — | |
| Q4 2011 | +0.1% | — | — | |
| Q4 2013 | -3.7% | — | — | |
| Q3 2012 | -0.5% | — | — | |
| Q3 2013 | -2.1% | — | — | |
| Q2 2012 | -1.4% | — | — | |
| Q2 2013 | -0.0% | — | — | |
| Q1 2012 | +0.9% | — | — | |
| Q4 2012 | +0.9% | — | — | |
| Q1 2013 | +2.2% | — | — | |
| Q3 2011 | — | — | — | |
| Q2 2011 | — | — | — | |
| Q1 2011 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro